Affronti, M. L., Woodring, S., Peters, K. B., Herndon, J. E., McSherry, F., Healy, P. N., . . . Friedman, H. S. (2016). A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab. Ther Clin Risk Manag.

Affronti, Mary Lou, Sarah Woodring, Katherine B. Peters, James E. Herndon, Frances McSherry, Patrick N. Healy, Annick Desjardins, James J. Vredenburgh, and Henry S. Friedman. "A Phase II Single-arm Trial of Palonosetron for the Prevention of Acute and Delayed Chemotherapy-induced Nausea and Vomiting in Malignant Glioma Patients Receiving Multidose Irinotecan in Combination With Bevacizumab." Ther Clin Risk Manag 2016.

Affronti, Mary Lou, et al. "A Phase II Single-arm Trial of Palonosetron for the Prevention of Acute and Delayed Chemotherapy-induced Nausea and Vomiting in Malignant Glioma Patients Receiving Multidose Irinotecan in Combination With Bevacizumab." Ther Clin Risk Manag 2016.